We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hemostasis Analyzer Provides Clotting, Chromogenic, and Immunoturbidimetric Testing Capabilities

By Labmedica staff writers
Posted on 06 Aug 2008
A powerful hemostasis analyzer has been developed for mid-high volume laboratories.

Called the ACL TOP 500 CTS (closed tube sampling) hemostasis analyzer, it is the newest addition to the family of ACL TOP systems, and was released by Beckman Coulter (Fullerton, CA, USA) in partnership with Instrument Laboratory (IL; Huntington Beach, CA, USA). More...


The hemostasis analyzer offers 24-hour, 7-day continuous operation without workflow interruption. It can hold 800 cuvettes and delivers up to 240 tests per hour. Cap piercing is automated and results arrive quickly, with prothrombin time (PT) reported in three minutes or less.

The analyzer provides clotting, chromogenic and immunoturbidimetric testing capabilities with a complete menu of routine and specialty assays. Its LED-based clot detection allows it to read clot-based assays at 671 nm, which helps minimize the effects of most preanalytic variables. The interface is user-friendly and operators need only a minimal amount of training.

The TOP 500 CTS is a compact, powerful analyzer that helps labs maximize labor resources, reduce turnaround time, and improve patient care.

Beckman Coulter provides a wide range of coagulation analyzers that deliver consistent, quality results with minimal maintenance. The wide selection of specialty assays and reagents are also designed to maximize the labs' capabilities. The company also offers service to enable the labs to operate at peak efficiency.


Related Links:
Beckman Coulter

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.